Phenoxy heterocyclic amines and use thereof
    1.
    发明授权
    Phenoxy heterocyclic amines and use thereof 失效
    苯氧基杂环胺及其用途

    公开(公告)号:US4225608A

    公开(公告)日:1980-09-30

    申请号:US21277

    申请日:1979-03-16

    摘要: Phenoxyalkylamines of the formulaAr--O--Rwherein Ar is phenyl or phenyl which is monosubstituted or disubstituted by F, Cl, Br, alkyl or alkoxy each of 1-4 carbon atoms, cycloalkoxy of 3-6 carbon atoms, CF.sub.3, CN, alkylthio of 1-4 carbon atoms, SCF.sub.3, OH and/or alkanoyloxy with 1-10 carbon atoms; R is (1-R.sup.1 -2-pyrrolidyl)--CH.sub.2 --CHR.sup.2 --, (1-R.sup.1 -2-piperidyl)-CH.sub.2 --CHR.sup.2 -- or 1-R.sup.1 -3-Z-4-hexahydroazepinyl; R.sup.1 is H, alkyl or alkenyl each of up to 4 carbon atoms, cyclopropylmethyl or benzyl; R.sup.2 is H, alkyl of 1-4 carbon atoms or phenyl; and Z is alkyl of 1-4 carbon atoms with the proviso that Ar is p-fluorophenyl only if R is not 2-(1-methyl-2-piperidyl)-ethyl; and the physiologically acceptable acid addition salts thereof, possess valuable pharmacological properties, e.g., are antidepressants.

    摘要翻译: 式Ar-OR的苯氧基烷基胺其中Ar是苯基或被1-4个碳原子的F,Cl,Br,烷基或烷氧基单取代或二取代的苯基,3-6个碳原子的环烷氧基,CF 3,CN,烷硫基 1-4个碳原子,SCF 3,OH和/或具有1-10个碳原子的烷酰氧基; R 1是(1-R 1 - 吡咯烷基)-CH 2 -CHR 2 - ,(1-R 1 -2-哌啶基)-CH 2 -CHR 2 - 或1-R 1-3 -Z-4-六氢氮杂基; R1是H,最多4个碳原子的烷基或链烯基,环丙基甲基或苄基; R2是H,1-4个碳原子的烷基或苯基; 并且Z是1-4个碳原子的烷基,条件是仅当R不是2-(1-甲基-2-哌啶基) - 乙基时,Ar是对氟苯基; 及其生理上可接受的酸加成盐具有有价值的药理学性质,例如抗抑郁药。

    Isoquinolines and anti-depressants containing them
    3.
    发明授权
    Isoquinolines and anti-depressants containing them 失效
    含有异喹啉和抗抑郁剂

    公开(公告)号:US4122180A

    公开(公告)日:1978-10-24

    申请号:US806240

    申请日:1977-06-13

    CPC分类号: C07D401/12

    摘要: Isoquinolines of the formula ##STR1## wherein R.sup.1 is H or alkyl of 1 - 4 carbon atoms, R.sup.2 is H and R.sup.3 is OH or R.sup.2 and R.sup.3 collectively are a C--C bond, and physiologically acceptable acid addition salts thereof have anti-depressant activity and can be prepared by solvolyzing or hydrogenolyzing a compound of the formula ##STR2## or an acid addition salt thereof, wherein R.sup.4 is R.sup.1 or R.sup.6, R.sup.5 is OR.sup.7 or, when R.sup.4 is R.sup.6, R.sup.3 ; R.sup.6 and R.sup.7 are radicals which can be split off solvolytically or hydrogenolytically and R.sup.1 and R.sup.2 are as above; and the optional step of dehydrating a resulting carbinol (R.sup.2 is H, R.sup.3 is OH) and/or treating a resulting compound (R.sup.1 is H) with a N-alkylating agent and/or converting a resulting base to a physiologically acceptable acid addition salt by treatment with and acid.

    摘要翻译: 其中R 1为H或1-4个碳原子的烷基,R 2为H且R 3为OH或R 2和R 3为CC键,其生理学上可接受的酸加成盐具有抗抑郁活性, 可以通过溶剂化或氢解式IMA的化合物或其酸加成盐,其中R 4是R 1或R 6,R 5是OR 7,或者当R 4是R 6时,R 3; R6和R7是可以溶剂分解或氢解分解的自由基,R1和R2如上所述; 和将所得的甲醇(R2是H,R3是OH)脱水和/或用N-烷基化剂处理所得化合物(R1是H)和/或将得到的碱转化为生理上可接受的酸加成盐的任选步骤 通过处理和酸。